Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis
Eva Bagyinszky, Vo Van Giau, Kyu-Hwan Shim, et al.
Journal of the Neurological Sciences (2017) Vol. 376, pp. 242-254
Closed Access | Times Cited: 236

Showing 1-25 of 236 citing articles:

The Lancet Commission on global mental health and sustainable development
Vikram Patel, Shekhar Saxena, Crick Lund, et al.
The Lancet (2018) Vol. 392, Iss. 10157, pp. 1553-1598
Open Access | Times Cited: 2346
History and progress of hypotheses and clinical trials for Alzheimer’s disease
Peipei Liu, Yi Xie, Xiao‐Yan Meng, et al.
Signal Transduction and Targeted Therapy (2019) Vol. 4, Iss. 1
Open Access | Times Cited: 569
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Mengwei Li, Xiaowei Chi, Ying Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 394
Antibiotics, gut microbiota, and Alzheimer’s disease
Francesco Angelucci, Kateřina Čechová, Jana Amlerová, et al.
Journal of Neuroinflammation (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 371
The progress of gut microbiome research related to brain disorders
Sibo Zhu, Yanfeng Jiang, Kelin Xu, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 355
Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial
Gary W. Small, Prabha Siddarth, Zhaoping Li, et al.
American Journal of Geriatric Psychiatry (2017) Vol. 26, Iss. 3, pp. 266-277
Open Access | Times Cited: 268
Type 3 Diabetes and Its Role Implications in Alzheimer’s Disease
Thuy Trang Nguyen, Qui Thanh Hoai Ta, Thi Kim Oanh Nguyen, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3165-3165
Open Access | Times Cited: 250
The Microbiota–Gut–Brain Axis and Alzheimer’s Disease: Neuroinflammation Is to Blame?
Ashwinipriyadarshini Megur, Daiva Baltriukienė, Virginija Bukelskienė, et al.
Nutrients (2020) Vol. 13, Iss. 1, pp. 37-37
Open Access | Times Cited: 227
Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer’s disease
Rishika Dhapola, Subhendu Shekhar Hota, Phulen Sarma, et al.
Inflammopharmacology (2021) Vol. 29, Iss. 6, pp. 1669-1681
Open Access | Times Cited: 227
Gut Microbiota and Their Neuroinflammatory Implications in Alzheimer’s Disease
Vo Van Giau, Si Wu, Angelo Jamerlan, et al.
Nutrients (2018) Vol. 10, Iss. 11, pp. 1765-1765
Open Access | Times Cited: 199
The Regulatory Role of IL-10 in Neurodegenerative Diseases
Chiara Porro, Antonia Cianciulli, Maria Antonietta Panaro
Biomolecules (2020) Vol. 10, Iss. 7, pp. 1017-1017
Open Access | Times Cited: 164
Proinflammatory and anti-inflammatory cytokines in the CSF of patients with Alzheimer's disease and their correlation with cognitive decline
Ricardo Taipa, Sofia Pereira das Neves, Ana Luísa Sousa, et al.
Neurobiology of Aging (2019) Vol. 76, pp. 125-132
Open Access | Times Cited: 162
Nanotechnology-based drug delivery for central nervous system disorders
Thuy Trang Nguyen, Thi Thuy Dung Nguyen, Tuong Kha Vo, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112117-112117
Open Access | Times Cited: 108
Exploring the mechanisms of kaempferol in neuroprotection: Implications for neurological disorders
Amir Mohammad Nezhad Salari, Zahra Rasoulizadeh, Arezoo Gowhari Shabgah, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Closed Access | Times Cited: 15
Fecal microbiota transplantation attenuates Alzheimer’s disease symptoms in APP/PS1 transgenic mice via inhibition of the TLR4-MyD88-NF-κB signaling pathway-mediated inflammation
Xiang Li, Qingyong Ding, Xinxin Wan, et al.
Behavioral and Brain Functions (2025) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer’s disease: Rational insights for the therapeutic approaches
Mir Hilal Ahmad, Mahino Fatima, Amal Chandra Mondal
Journal of Clinical Neuroscience (2018) Vol. 59, pp. 6-11
Closed Access | Times Cited: 152
Microbiome-Derived Lipopolysaccharide Enriched in the Perinuclear Region of Alzheimer’s Disease Brain
Yuhai Zhao, Lin Cong, Vivian Jaber, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 143
MFG‐E8 reverses microglial‐induced neurotoxic astrocyte (A1) via NF‐κB and PI3K‐Akt pathways
Xiaotian Xu, Aiwu Zhang, Yingting Zhu, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 1, pp. 904-914
Open Access | Times Cited: 143
Role of the peripheral innate immune system in the development of Alzheimer's disease
Aurélie Le Page, Gilles Dupuis, Éric Frost, et al.
Experimental Gerontology (2017) Vol. 107, pp. 59-66
Closed Access | Times Cited: 139
Panax ginseng as an adjuvant treatment for Alzheimer's disease
Hyeon-Joong Kim, Jung Woo Shin, Seog-Young Kim, et al.
Journal of Ginseng Research (2018) Vol. 42, Iss. 4, pp. 401-411
Open Access | Times Cited: 132
Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE/NF-κB signaling pathway in vivo and in vitro
Bo Ding, Chengheng Lin, Qian Liu, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 129
Current and emerging avenues for Alzheimer's disease drug targets
Raúl Loera‐Valencia, Ángel Cedazo-Mı́nguez, Paul-Ariel Kenigsberg, et al.
Journal of Internal Medicine (2019) Vol. 286, Iss. 4, pp. 398-437
Open Access | Times Cited: 118
Neutralization of IL‐17 rescues amyloid‐β‐induced neuroinflammation and memory impairment
Claudia Cristiano, Floriana Volpicelli, Pellegrino Lippiello, et al.
British Journal of Pharmacology (2019) Vol. 176, Iss. 18, pp. 3544-3557
Open Access | Times Cited: 114
An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition
Andrea Terron, Anna Bal‐Price, Alicia Paini, et al.
Archives of Toxicology (2017) Vol. 92, Iss. 1, pp. 41-82
Open Access | Times Cited: 104
Preventive and therapeutic potential of ascorbic acid in neurodegenerative diseases
Morgana Moretti, Daiane B. Fraga, Ana Lúcia S. Rodrigues
CNS Neuroscience & Therapeutics (2017) Vol. 23, Iss. 12, pp. 921-929
Open Access | Times Cited: 97
Page 1 - Next Page

Scroll to top